Sign in

CIK 0002044725

  • Emerging growth company

Evommune, Inc.

Sign in to watch
Ticker
EVMN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850742575
Phone
+1 650-223-7745
Business address
1891 PAGE MILL RD, PALO ALTO, CA
  1. 4 Open-market buy Director bought 1,250,000 shares at $16.00 ($20,000,000)
  2. 4 Open-market buy 10% owner bought 1,562,500 shares at $16.00 ($25,000,000)
  3. 4 Open-market buy Director bought 1,562,500 shares at $16.00 ($25,000,000)
  4. 4 Conversion President & CEO acquired 24,225 shares (conversion)
  5. 4 Conversion Chief Scientific Officer acquired 3,175 shares (conversion)
  6. 4 Conversion Chief Business & Legal Officer acquired 3,175 shares (conversion)
  7. 4 Conversion Director acquired 3,371,001 shares (conversion)
  8. 4 Conversion EVP, Operations acquired 1,587 shares (conversion)
  9. 4 Conversion Director acquired 6,056 shares (conversion)
  10. 4 Conversion Chief Financial Officer acquired 3,175 shares (conversion)
  11. 4 Conversion Chief Medical Officer acquired 25,812 shares (conversion)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 4 · 74 filings